Profound Medical (PROF) Profit After Tax (2018 - 2026)

Profound Medical has reported Profit After Tax for 9 years, with the latest figure at -$7.1 million in Q1 2026.

• For the quarter ending Q1 2026, Profit After Tax rose 34.23% year-over-year to -$7.1 million; the trailing twelve-month figure through Mar 2026 stood at -$38.9 million (down 21.73% YoY), and the FY2025 full-year result was -$42.6 million, down 53.04% from the prior year.
• Profit After Tax for Q1 2026 stood at -$7.1 million, up from -$8.2 million in the prior quarter.
• The five-year high for Profit After Tax was $22.4 million in Q2 2022, with the low at -$47.8 million in Q4 2022.
• Average Profit After Tax over 5 years is -$5.6 million, with a median of -$7.1 million recorded in 2026.
• Year-over-year, Profit After Tax jumped 182.06% in 2023 and sank 667.92% in 2024.
• Tracing PROF's Profit After Tax over 5 years: stood at -$47.8 million in 2022, then jumped by 81.88% to -$8.7 million in 2023, then surged by 42.9% to -$4.9 million in 2024, then plunged by 65.25% to -$8.2 million in 2025, then gained by 13.72% to -$7.1 million in 2026.
• The last three Profit After Tax figures came in at -$7.1 million (Q1 2026), -$8.2 million (Q4 2025), and -$8.0 million (Q3 2025), per Business Quant data.

Peer Comparison